Literature DB >> 23105467

Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients.

M S Rukmini1, Benedicta D'Souza, Vivian D'Souza.   

Abstract

Free radical mediated pathological processes may have a role in schizophrenia. Free radicals (oxy radicals, such as superoxide, hydroxyl ions and nitric oxide) cause cell injury, when they are generated in excess or when the antioxidant defense is impaired. Both these processes seem to be affected in schizophrenia. In this study we investigated erythrocyte superoxide dismutase (SOD) and catalase (CAT) activities as antioxidant enzymes, malondialdehyde (MDA) as a sign of lipid peroxidation in schizophrenic patients. Activities of superoxide dismutase, catalase and malondialdehyde were greater in patients compared with the control group which may reflect increased oxidative stress in the brain tissue of schizophrenics. In the patient group erythrocyte SOD and CAT activities were weakly negative correlated with MDA concentration. These data reveal that antioxidant defense mechanisms might be impaired in schizophrenic patients. These findings also provide a theoretical basis for the development of novel therapeutic strategies, such as antioxidant supplementation.

Entities:  

Keywords:  Catalase; Lipid peroxidation; Schizophrenia; Superoxide dismutase

Year:  2004        PMID: 23105467      PMCID: PMC3454217          DOI: 10.1007/BF02894268

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  24 in total

1.  Enzymes of the antioxidant defense system in chronic schizophrenic patients.

Authors:  R Reddy; M P Sahebarao; S Mukherjee; J N Murthy
Journal:  Biol Psychiatry       Date:  1991-08-15       Impact factor: 13.382

2.  The autoxidation of human red cell lipids induced by hydrogen peroxide.

Authors:  J Stocks; T L Dormandy
Journal:  Br J Haematol       Date:  1971-01       Impact factor: 6.998

3.  Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines.

Authors:  H S Pall; A C Williams; D R Blake; J Lunec
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

4.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Authors:  C D Smith; J M Carney; P E Starke-Reed; C N Oliver; E R Stadtman; R A Floyd; W R Markesbery
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

5.  A simple method for clinical assay of superoxide dismutase.

Authors:  Y Sun; L W Oberley; Y Li
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

Review 6.  Oxidative injury and potential use of antioxidants in schizophrenia.

Authors:  S P Mahadik; R E Scheffer
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1996-08       Impact factor: 4.006

7.  Hydrogen peroxide production by rat brain in vivo.

Authors:  P M Sinet; R E Heikkila; G Cohen
Journal:  J Neurochem       Date:  1980-06       Impact factor: 5.372

Review 8.  Oxygen radicals and neuropsychiatric illness. Some speculations.

Authors:  J B Lohr
Journal:  Arch Gen Psychiatry       Date:  1991-12

Review 9.  Reactive oxygen species and the central nervous system.

Authors:  B Halliwell
Journal:  J Neurochem       Date:  1992-11       Impact factor: 5.372

10.  The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects.

Authors:  R G McCreadie; E MacDonald; D Wiles; G Campbell; J R Paterson
Journal:  Br J Psychiatry       Date:  1995-11       Impact factor: 9.319

View more
  18 in total

Review 1.  Potential drug targets and treatment of schizophrenia.

Authors:  Anil Kumar; Monu Yadav; Milind Parle; Sameer Dhingra; Dinesh K Dhull
Journal:  Inflammopharmacology       Date:  2017-03-28       Impact factor: 4.473

2.  Phycoerythrin averts intracellular ROS generation and physiological functional decline in eukaryotes under oxidative stress.

Authors:  Ravi R Sonani; Rajesh P Rastogi; Niraj K Singh; Jaymesh Thadani; Puja J Patel; Jitendra Kumar; Anand K Tiwari; Ranjitsinh V Devkar; Datta Madamwar
Journal:  Protoplasma       Date:  2016-06-22       Impact factor: 3.356

3.  Decreasing the diabetic complication by vanadyl(VO)2+/vitamin B 6 complex in alloxan-induced diabetic mice.

Authors:  Nahla S El-Shenawy; Moamen S Refat; Fatima H Fakihi
Journal:  J Mater Sci Mater Med       Date:  2013-02-09       Impact factor: 3.896

4.  Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia.

Authors:  Zhi-Le Bai; Xue-Song Li; Guang-Yang Chen; Yang Du; Ze-Xu Wei; Xi Chen; Guang-En Zheng; Wen Deng; Yong Cheng
Journal:  J Mol Neurosci       Date:  2018-10-09       Impact factor: 3.444

5.  Oxidative stress in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

6.  Effect of thioridazine on antioxidant status of HEMn-DP melanocytes.

Authors:  Michał Otręba; Artur Beberok; Dorota Wrześniok; Jakub Rok; Ewa Buszman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-24       Impact factor: 3.000

7.  Antiepileptic and Antioxidant Effect of Hydroalcoholic Extract of Ferula Assa Foetida Gum on Pentylentetrazole- induced Kindling in Male Mice.

Authors:  Zahra Kiasalari; Mohsen Khalili; Mehrdad Roghani; Hamid Heidari; Yaser Azizi
Journal:  Basic Clin Neurosci       Date:  2013

8.  Evaluation of antioxidant deficit in schizophrenia.

Authors:  Gora Dadheech; Sandhya Mishra; Shiv Gautam; Praveen Sharma
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

9.  The preventive effect of atorvastatin on liver fibrosis in the bile duct ligation rats via antioxidant activity and down-regulation of Rac1 and NOX1.

Authors:  Zohreh-Al-Sadat Ghoreshi; Razieh Kabirifar; Ameneh Khodarahmi; Alireza Karimollah; Ali Moradi
Journal:  Iran J Basic Med Sci       Date:  2020-01       Impact factor: 2.699

10.  Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition.

Authors:  Cristina Gonzalez-Liencres; Cumhur Tas; Elliot C Brown; Soner Erdin; Ece Onur; Zeynep Cubukcoglu; Omer Aydemir; Aysen Esen-Danaci; Martin Brüne
Journal:  BMC Psychiatry       Date:  2014-09-24       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.